Pelican Point Dialysis - DaVita Clinical Research — Las Vegas, Nevada

Pelican Point Dialysis - DaVita Clinical Research is a clinical research site located in Las Vegas, Nevada, United States 89129.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Pelican Point Dialysis - DaVita Clinical Research has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Kidney Disease, IgA Nephropathy, Immunoglobulin A Nephropathy.

Sponsors: Gilead Sciences, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Las Vegas

Browse all research sites in Nevada · View every site in Las Vegas

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pelican Point Dialysis - DaVita Clinical Research?

Pelican Point Dialysis - DaVita Clinical Research has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pelican Point Dialysis - DaVita Clinical Research conducted?

Pelican Point Dialysis - DaVita Clinical Research has 2 clinical trials on record, with 1 currently active. Their work covers Diabetic Kidney Disease, IgA Nephropathy, Immunoglobulin A Nephropathy.

Is Pelican Point Dialysis - DaVita Clinical Research accredited by Crixeo Clinical Trials?

Pelican Point Dialysis - DaVita Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pelican Point Dialysis - DaVita Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.